A detailed history of Hexagon Capital Partners LLC transactions in Galapagos Nv stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 5 shares of GLPG stock, worth $151. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Holding current value
$151
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$24.2 - $30.67 $121 - $153
5 New
5 $0
Q4 2022

Jan 13, 2023

SELL
$37.44 - $46.51 $4,268 - $5,302
-114 Reduced 70.81%
47 $0
Q3 2022

Oct 17, 2022

BUY
$42.27 - $57.6 $6,805 - $9,273
161 New
161 $7,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.99B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.